Recognized by CB Insights and Financial Times as one of the most promising Digital Health companies in the world, iLoF is building an AI-powered breakthrough platform capable of transforming precision medicine. […]
Thanks to our proprietary optical fingerprint library of disease biomarkers and biological profiles we can offer personalized patient screening and stratification in a faster and more affordable way, saving up to 40% of the cost and 70% of the time while enabling a more human patient experience. […]
Recognized by CB Insights as one of the most promising Digital Health companies in the...